ReviewPediatric nephrology (Berlin, Germany)2026
Little kidneys amid large global inequities.
Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical complications and anthropometric indicators of chronic kidney disease in a global context: scoping review.Pediatric nephrology (Berlin, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic kidney disease (CKD) is a common non-communicable disease in children, and kidney dysfunction is the leading metabolic risk factor for death. Despite this, awareness of the CKD burden remains limited, and significant inequities exist in access to diagnosis and care worldwide. Kidney disease risk in children begins in utero and is dependent on the mother's health and wellbeing. This is further impacted each day by poverty, nutrition, education, infection, and safety. Greater community awareness is needed, especially in lower resource settings, where children present late and may have no access to care. Early diagnosis, possibly supported by screening at schools, can have important public and individual health consequences. Catastrophic health expenditure is common if families attempt to pay out of pocket for kidney replacement therapy. Health systems require strengthening from the antenatal clinic through tertiary care to ensure children with kidney disease are identified and treated early, appropriately, affordably, and well. Local non-governmental organizations have had some success in mitigating inequities. Governments must step up, measure, and acknowledge the burden of kidney disease in children, ensure appropriate public health measures to reduce risk, strengthen primary care to improve the quality of diagnosis and care, and progressively scale up equitable access to all forms of kidney care. Kidney disease risk is strongly linked with social and structural determinants of health. A holistic approach to supporting child wellbeing-outlined by the Sustainable Development Goals and a One Health Approach-will positively impact child kidney health and promote equity among all children.
Indexed as
Identifiers
41673301What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.